With participation from Baillie Gifford, Loyal’s latest funding builds on recent regulatory milestones and brings the company closer to market readiness Loyal, a clinical-stage animal health company ...
What if dogs could live longer and healthier lives? Loyal’s Celine Halioua has raised $135 million from top investors to develop canine longevity pills—and expects to get her first conditional ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results